Occupe actuellement un poste chez Syndax Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
President, Chief Operating Officer, Director | Syndax Pharmaceuticals Inc | 4 juillet 2019 - |
President, Chief Operating Officer | Syndax Pharmaceuticals Inc | 5 mai 2015 - 4 juillet 2019 |
Executive Vice President and Chief Operating Officer | Mersana Therapeutics Inc | None - |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2023-02-08 | 2023-02-06 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
5 959
-25.2%
27,64164 697 USD |
5 959 -25.2% | 27,64 | 164 697 USD | |
2022-11-10 | 2022-11-08 |
CTI Biopharma Corp
(CTIC)
|
VP Vente planifiée |
4 500
-100.0%
5,7025 660 USD |
4 500 -100.0% | 5,70 | 25 660 USD | |
2022-11-10 | 2022-11-08 |
CTI Biopharma Corp
(CTIC)
|
VP Vente planifiée |
36 942
-89.1%
5,65208 578 USD |
36 942 -89.1% | 5,65 | 208 578 USD | |
2022-11-10 | 2022-11-08 |
CTI Biopharma Corp
(CTIC)
|
VP Vente planifiée |
50 058
-54.7%
5,53276 781 USD |
50 058 -54.7% | 5,53 | 276 781 USD | |
2022-10-07 | 2022-10-06 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
16 231
-47.9%
25,29410 508 USD |
16 231 -47.9% | 25,29 | 410 508 USD | |
2022-10-04 | 2022-10-04 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
1 280
-6.8%
25,0232 026 USD |
1 280 -6.8% | 25,02 | 32 026 USD | |
2022-10-04 | 2022-10-03 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
2 883
-14.0%
25,0172 107 USD |
2 883 -14.0% | 25,01 | 72 107 USD | |
2022-10-04 | 2022-09-30 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
29 606
-62.6%
25,02740 757 USD |
29 606 -62.6% | 25,02 | 740 757 USD | |
2022-07-07 | 2022-07-05 |
CTI Biopharma Corp
(CTIC)
|
VP Vente planifiée |
3 331
-14.2%
6,2320 737 USD |
3 331 -14.2% | 6,23 | 20 737 USD | |
2022-07-07 | 2022-07-05 |
CTI Biopharma Corp
(CTIC)
|
VP Vente planifiée |
27 506
-54.0%
6,14168 895 USD |
27 506 -54.0% | 6,14 | 168 895 USD | |
2022-07-07 | 2022-07-05 |
CTI Biopharma Corp
(CTIC)
|
VP Vente planifiée |
51 963
-50.5%
6,05314 439 USD |
51 963 -50.5% | 6,05 | 314 439 USD | |
2022-07-07 | 2022-07-05 |
CTI Biopharma Corp
(CTIC)
|
VP Vente planifiée |
8 700
-7.8%
5,9851 996 USD |
8 700 -7.8% | 5,98 | 51 996 USD | |
2021-12-20 | 2021-12-20 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
45 000
-71.8%
20,29912 960 USD |
45 000 -71.8% | 20,29 | 912 960 USD | |
2021-12-20 | 2021-12-20 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
16 000
-47.5%
20,29324 608 USD |
16 000 -47.5% | 20,29 | 324 608 USD | |
2021-12-20 | 2021-12-17 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
1 676
-8.7%
19,0231 877 USD |
1 676 -8.7% | 19,02 | 31 877 USD | |
2021-12-20 | 2021-12-16 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
22 715
-56.3%
19,08433 400 USD |
22 715 -56.3% | 19,08 | 433 400 USD | |
2021-12-15 | 2021-12-13 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
34 564
-66.2%
19,05658 555 USD |
34 564 -66.2% | 19,05 | 658 555 USD | |
2021-12-15 | 2021-12-13 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
2 045
-10.4%
19,0538 964 USD |
2 045 -10.4% | 19,05 | 38 964 USD | |
2021-10-27 | 2021-10-26 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
16 296
-48.0%
19,20312 825 USD |
16 296 -48.0% | 19,20 | 312 825 USD | |
2021-10-27 | 2021-10-25 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
44 704
-71.7%
19,13855 335 USD |
44 704 -71.7% | 19,13 | 855 335 USD | |
2021-09-28 | 2021-09-27 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
24 437
-58.1%
19,51476 832 USD |
24 437 -58.1% | 19,51 | 476 832 USD | |
2021-02-03 | 2021-02-01 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
15 000
-45.9%
20,19302 799 USD |
15 000 -45.9% | 20,19 | 302 799 USD | |
2020-12-03 | 2020-12-01 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
15 000
-45.9%
22,97344 513 USD |
15 000 -45.9% | 22,97 | 344 513 USD | |
2020-11-06 | 2020-11-04 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
100 000
-85.0%
20,312 031 410 USD |
100 000 -85.0% | 20,31 | 2 031 410 USD |